Issue Date | Title | Author(s) |
2018 | Accessibility and safety of antipsychotics in the treatment of Autism Spectrum Disorder in children and adolescents | Sadaf, Shaista |
2018-10 | Accessibility and safety of antipsychotics in the treatment of autism spectrum disorder in children and adolescents | Sadaf, Shaista; Mifsud Buhagiar, Luana; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
2007 | Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors : a PET study in schizophrenia | Mizrahi, Romina; Rusjan, Pablo; Agid, Ofer; Graff-Guerrero, Ariel; Mamo, David; Zipursky, Robert B.; Kapur, Shitij |
2010 | Analysis of antipsychotic dose reduction | Uchida, Hiroyuki; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Mamo, David |
2008 | The antipsychotic potential of l-stepholidine : a naturally occurring dopamine receptor D1 agonist and D2 antagonist | Natesan, Sridhar; Reckless, Greg E.; Barlow, Karen B. L.; Odontiadis, John; Nobrega, Jose N.; Baker, Glen B.; George, Susan R.; Mamo, David; Kapur, Shitij |
2013-06 | Antipsychotics and Aeds : therapeutic drug monitoring in a mental health care setting | Mifsud, Janet; Vella, T.; Ellul-Micallef, Roger |
2010 | Are antipsychotic prescribing patterns different in older and younger adults? : a survey of 1357 psychiatric inpatients in Toronto | Sproule, Beth A.; Lake, Jennifer; Mamo, David; Uchida, Hiroyuki; Mulsant, Benoit H. |
2002 | Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT2C receptors in vivo | Di Matteo, Vincenzo; Cacchio, Marisa; Di Giulio, Camillo; Di Giovanni, Giuseppe; Esposito, Ennio |
2015 | Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy : the missing link? | Guiard, Bruno P.; Di Giovanni, Giuseppe |
2012 | Defining treatment-resistant schizophrenia and response to antipsychotics : a review and recommendation | Suzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mimura, Masaru; Mamo, David |
2007 | Differential effects of aripiprazole on D 2, 5-HT 2, and 5-HT 1A receptor occupancy in patients with schizophrenia : a triple tracer PET study | Mamo, David; Graff-Guerrero, Ariel; Mizrahi, Romina; Shammi, Chekkera M.; Romeyer, Franvoise; Kapur, Shitij |
2015 | Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trial | Nakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel |
2012 | Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE data | Sakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki |
2012 | Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional study | Mizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki |
2004 | Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine | Mamo, David; Remington, Gary; Nobrega, Jose N.; Hussey, Doug; Chirakal, Raman; Wilson, Alan A.; Baker, Glen B.; Houle, Sylvain; Kapur, Shitij |
2021 | The effectiveness of quetiapine in improving behavioural and psychological symptoms in older adults with dementia | Xuereb, Crissel (2021) |
2011 | Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume corrections | Uchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel |
2013 | Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE data | Moriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki |
2016 | Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brain | Caravaggio, Fernando; Kegeles, Lawrence S.; Wilson, Alan A.; Remington, Gary; Borlido, Carol; Mamo, David; Graff-Guerrero, Ariel |
2012 | Haloperidol for agitation in persons with dementia. | Debono, Michael |
2016 | Hearing voices : comparing the hearing voices approach with antipsychotic medication in adults | Micallef, Miriam |
2006 | High-dose quetiapine and photopsia | Hazra, Monica; Culo, Sandi; Mamo, David |
2011 | Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia | Hazra, Monica; Uchida, Hiroyuki; Sproule, Beth A.; Remington, Gary; Suzuki, Takefumi; Mamo, David |
2009 | The intersection of pharmacology, imaging, and genetics in the development of personalized medicine | Gerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G. |
2009 | Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychotics | Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David |
2004 | A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone | Mamo, David; Kapur, Shitij; Shammi, Chekkera M.; Papatheodorou, George; Mann, Steve; Therrien, Francois; Remington, Gary |
2009 | Predicting age‐specific dosing of antipsychotics | Uchida, Hiroyuki; Pollock, Bruce G.; Bies, Robert R.; Mamo, David |
2012 | Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic study | Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R. |
2007 | Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection | Odontiadis, John; MacKenzie, Erin M.; Natesan, Sridhar; Mamo, David; Kapur, Shitij; Baker, Glen B. |
2009 | The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics | Mizrahi, Romina; Mamo, David; Rusjan, Pablo; Graff, Ariel; Houle, Sylvain; Kapur, Shitij |
2010 | Role of serotonin in central dopamine dysfunction | Di Giovanni, Giuseppe; Esposito, Ennio; Di Matteo, Vincenzo |
2010 | Sensitivity to antipsychotic drugs in older adults | Leon, Chloe; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Rajji, Tarek K.; Mamo, David |
2015 | Serotonergic modulation of the activity of mesencephalic dopaminergic systems : therapeutic implications | De Deurwaerdère, Philippe; Di Giovanni, Giuseppe |
2008 | Serotonin control of central dopaminergic function : focus on in vivo microdialysis studies | Di Matteo, Vincenzo; Di Giovanni, Giuseppe; Pierucci, Massimo; Esposito, Ennio |
2023 | Serum prolactin monitoring in patients on risperidone admitted to the acute wards at Mount Carmel hospital | Gambin, Rachel; Diacono, Sheriseane; Mizzi, Therese Ann; East, Rachel Taylor |
2007 | Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response - a double-blind PET study in schizophrenia | Agid, Ofer; Mamo, David; Ginovart, Nathalie; Vitcu, Irina; Wilson, Alan A.; Zipursky, Robert B.; Kapur, Shitij |
2009 | Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT 2A) receptors in older, healthy adults | Chow, Tiffany W.; Mamo, David; Uchida, Hiroyuki; Graff- Guerrero, Ariel; Houle, Sylvain; Smith, Gwenn S.; Pollock, Bruce G.; Mulsant, Benoit H. |
2017 | Treating negative symptoms of schizophrenia : antipsychotics vs. antidepressants and antipsychotics | Saliba, Alexei Silvan |
2010 | The use of antipsychotics in institutionalized elderly patients with dementia | Bugeja, Vincent (2010) |